<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37709948</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-4766</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Nature reviews. Neurology</Title><ISOAbbreviation>Nat Rev Neurol</ISOAbbreviation></Journal><ArticleTitle>The amyotrophic lateral sclerosis exposome: recent advances and future directions.</ArticleTitle><Pagination><StartPage>617</StartPage><EndPage>634</EndPage><MedlinePgn>617-634</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41582-023-00867-2</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal disease of motor neuron degeneration with typical survival of only 2-5 years from diagnosis. The causes of ALS are multifactorial: known genetic mutations account for only around 70% of cases of familial ALS and 15% of sporadic cases, and heritability estimates range from 8% to 61%, indicating additional causes beyond genetics. Consequently, interest has grown in environmental contributions to ALS risk and progression. The gene-time-environment hypothesis posits that ALS onset occurs through an interaction of genes with environmental exposures during ageing. An alternative hypothesis, the multistep model of ALS, suggests that several hits, at least some of which could be environmental, are required to trigger disease onset, even in the presence of highly penetrant ALS-associated mutations. Studies have sought to characterize the ALS exposome - the lifetime accumulation of environmental exposures that increase disease risk and affect progression. Identifying the full scope of environmental toxicants that enhance ALS risk raises the prospect of preventing&#xa0;disease by eliminating or mitigating exposures. In this Review, we summarize the evidence for an ALS exposome, discussing the strengths and limitations of epidemiological studies that have identified contributions from various sources. We also consider potential mechanisms of exposure-mediated toxicity and suggest future directions for ALS exposome research.</AbstractText><CopyrightInformation>&#xa9; 2023. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Goutman</LastName><ForeName>Stephen A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0001-8780-6637</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Savelieff</LastName><ForeName>Masha G</ForeName><Initials>MG</Initials><Identifier Source="ORCID">0000-0001-5575-2494</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jang</LastName><ForeName>Dae-Gyu</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hur</LastName><ForeName>Junguk</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-0736-2149</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of North Dakota, Grand Forks, ND, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feldman</LastName><ForeName>Eva L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0002-9162-2694</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, MI, USA. efeldman@umich.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NeuroNetwork for Emerging Therapies, University of Michigan, Ann Arbor, MI, USA. efeldman@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 TS000289</GrantID><Acronym>TS</Acronym><Agency>ATSDR CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 TS000327</GrantID><Acronym>TS</Acronym><Agency>ATSDR CDC HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 ES027221</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES030049</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS120926</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS127188</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013487">Research Support, U.S. Gov't, P.H.S.</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Neurol</MedlineTA><NlmUniqueID>101500072</NlmUniqueID><ISSNLinking>1759-4758</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000081413" MajorTopicYN="Y">Exposome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004781" MajorTopicYN="N">Environmental Exposure</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>14</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37709948</ArticleId><ArticleId IdType="doi">10.1038/s41582-023-00867-2</ArticleId><ArticleId IdType="pii">10.1038/s41582-023-00867-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363&#x2013;1380 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36116464</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(22)01272-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, R. H. &amp; Al-Chalabi, A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162&#x2013;172 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28700839</ArticleId><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman, S. A. et al. Recent advances in the diagnosis and prognosis of amyotrophic lateral sclerosis. Lancet Neurol. 21, 480&#x2013;493 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35334233</ArticleId><ArticleId IdType="pmc">9513753</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(21)00465-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman, S. A. et al. Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis. Lancet Neurol. 21, 465&#x2013;479 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35334234</ArticleId><ArticleId IdType="pmc">9513754</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(21)00414-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi, A. &amp; Hardiman, O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 9, 617&#x2013;628 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">24126629</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2013.203</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio, A. et al. The multistep hypothesis of ALS revisited: the role of genetic mutations. Neurology 91, e635&#x2013;e642 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30045958</ArticleId><ArticleId IdType="pmc">6105040</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000005996</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild, C. P. Complementing the genome with an &#x2018;exposome&#x2019;: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol. Biomark. Prev. 14, 1847&#x2013;1850 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-05-0456</ArticleId></ArticleIdList></Reference><Reference><Citation>Vineis, P. et al. What is new in the exposome? Environ. Int. 143, 105887 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32619912</ArticleId><ArticleId IdType="doi">10.1016/j.envint.2020.105887</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen, R., Schymanski, E. L., Barab&#xe1;si, A. L. &amp; Miller, G. W. The exposome and health: where chemistry meets biology. Science 367, 392&#x2013;396 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31974245</ArticleId><ArticleId IdType="pmc">7227413</ArticleId><ArticleId IdType="doi">10.1126/science.aay3164</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang, C. et al. Dynamic human environmental exposome revealed by longitudinal personal monitoring. Cell 175, 277&#x2013;291.e231 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30241608</ArticleId><ArticleId IdType="pmc">6472932</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2018.08.060</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar, M. et al. A roadmap to ALS prevention: strategies and priorities. J. Neurol. Neurosurg. Psychiatry 94, 399&#x2013;402 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36690429</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2022-330473</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin, B. et al. Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int. J. Epidemiol. 46, 57&#x2013;74 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27185810</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernoff, N. et al. A critical review of the postulated role of the non-essential amino acid, &#x3b2;-N-methylamino-L-alanine, in neurodegenerative disease in humans. J. Toxicol. Environ. Health B Crit. Rev. 20, 1&#x2013;47 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28598725</ArticleId><ArticleId IdType="pmc">6503681</ArticleId><ArticleId IdType="doi">10.1080/10937404.2017.1297592</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer, P. S. Hypothesis: etiologic and molecular mechanistic leads for sporadic neurodegenerative diseases based on experience with Western Pacific ALS/PDC. Front. Neurol. 10, 754 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31417480</ArticleId><ArticleId IdType="pmc">6685391</ArticleId><ArticleId IdType="doi">10.3389/fneur.2019.00754</ArticleId></ArticleIdList></Reference><Reference><Citation>Luker, J., Woodman, R. &amp; Schultz, D. The incidence and prevalence of motor neurone disease in South Australia. Amyotroph. Lateral Scler. Frontotemporal Degener. 24, 195&#x2013;202 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">35934980</ArticleId><ArticleId IdType="doi">10.1080/21678421.2022.2108326</ArticleId></ArticleIdList></Reference><Reference><Citation>Newell, M. E., Adhikari, S. &amp; Halden, R. U. Systematic and state-of the science review of the role of environmental factors in amyotrophic lateral sclerosis (ALS) or Lou Gehrig&#x2019;s disease. Sci. Total Environ. 817, 152504 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34971691</ArticleId><ArticleId IdType="doi">10.1016/j.scitotenv.2021.152504</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz, G. G., Rundquist, B. C., Simon, I. J. &amp; Swartz, S. E. Geographic distributions of motor neuron disease mortality and well water use in U.S. counties. Amyotroph. Lateral Scler. Frontotemporal Degener. 18, 279&#x2013;283 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28019106</ArticleId><ArticleId IdType="doi">10.1080/21678421.2016.1264975</ArticleId></ArticleIdList></Reference><Reference><Citation>Torbick, N., Hession, S., Stommel, E. &amp; Caller, T. Mapping amyotrophic lateral sclerosis lake risk factors across northern New England. Int. J. Health Geogr. 13, 1 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24383521</ArticleId><ArticleId IdType="pmc">3922844</ArticleId><ArticleId IdType="doi">10.1186/1476-072X-13-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown, C. A., Lally, C., Kupelian, V. &amp; Flanders, W. D. Estimated prevalence and incidence of amyotrophic lateral sclerosis and SOD1 and C9orf72 genetic variants. Neuroepidemiology 55, 342&#x2013;353 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34247168</ArticleId><ArticleId IdType="doi">10.1159/000516752</ArticleId></ArticleIdList></Reference><Reference><Citation>Elden, A. C. et al. Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature 466, 1069&#x2013;1075 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20740007</ArticleId><ArticleId IdType="pmc">2965417</ArticleId><ArticleId IdType="doi">10.1038/nature09320</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian, T. H. et al. Physical exercise is a risk factor for amyotrophic lateral sclerosis: convergent evidence from Mendelian randomisation, transcriptomics and risk genotypes. eBioMedicine 68, 103397 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34051439</ArticleId><ArticleId IdType="pmc">8170114</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2021.103397</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli, J. et al. Elevated levels of selenium species in cerebrospinal fluid of amyotrophic lateral sclerosis patients with disease-associated gene mutations. Neurodegener. Dis. 17, 171&#x2013;180 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28478440</ArticleId><ArticleId IdType="doi">10.1159/000460253</ArticleId></ArticleIdList></Reference><Reference><Citation>McCann, E. P. et al. Evidence for polygenic and oligogenic basis of Australian sporadic amyotrophic lateral sclerosis. J. Med. Genet. https://doi.org/10.1136/jmedgenet-2020-106866 (2020).</Citation></Reference><Reference><Citation>Bandres-Ciga, S. et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann. Neurol. 85, 470&#x2013;481 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30723964</ArticleId><ArticleId IdType="pmc">6450729</ArticleId><ArticleId IdType="doi">10.1002/ana.25431</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen, W. et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 48, 1043&#x2013;1048 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27455348</ArticleId><ArticleId IdType="pmc">5556360</ArticleId><ArticleId IdType="doi">10.1038/ng.3622</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi, A. et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J. Neurol. Neurosurg. Psychiatry 81, 1324&#x2013;1326 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20861059</ArticleId><ArticleId IdType="doi">10.1136/jnnp.2010.207464</ArticleId></ArticleIdList></Reference><Reference><Citation>McComas, A. J., Upton, A. R. M. &amp; Sica, R. E. P. Motoneurone disease and ageing. Lancet 302, 1477&#x2013;1480 (1973).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(73)92735-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi, A. et al. Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study. Lancet Neurol. 13, 1108&#x2013;1113 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25300936</ArticleId><ArticleId IdType="pmc">4197338</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(14)70219-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic, S. et al. Amyotrophic lateral sclerosis as a multi-step process: an Australia population study. Amyotroph. Lateral Scler. Frontotemporal Degener. 20, 532&#x2013;537 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31284763</ArticleId><ArticleId IdType="doi">10.1080/21678421.2018.1556697</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic, S. et al. ALS is a multistep process in South Korean, Japanese, and Australian patients. Neurology 94, e1657&#x2013;e1663 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32071166</ArticleId><ArticleId IdType="pmc">7251515</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000009015</ArticleId></ArticleIdList></Reference><Reference><Citation>Armitage, P. &amp; Doll, R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer 8, 1&#x2013;12 (1954).</Citation><ArticleIdList><ArticleId IdType="pubmed">13172380</ArticleId><ArticleId IdType="pmc">2007940</ArticleId><ArticleId IdType="doi">10.1038/bjc.1954.1</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis, E. et al. Genetic polymorphisms in amyotrophic lateral sclerosis: evidence for implication in detoxification pathways of environmental toxicants. Environ. Int. 116, 122&#x2013;135 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29677557</ArticleId><ArticleId IdType="doi">10.1016/j.envint.2018.04.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta, R., Chia, R., Traynor, B. J. &amp; Chi&#xf2;, A. Unraveling the complex interplay between genes, environment, and climate in ALS. eBioMedicine 75, 103795 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34974309</ArticleId><ArticleId IdType="doi">10.1016/j.ebiom.2021.103795</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer, P. S. Parkinsonism and motor neuron disorders: lessons from Western Pacific ALS/PDC. J. Neurol. Sci. 433, 120021 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34635325</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2021.120021</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, M. D., Little, J., Gomes, J., Cashman, N. R. &amp; Krewski, D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology 61, 101&#x2013;130 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27377857</ArticleId><ArticleId IdType="doi">10.1016/j.neuro.2016.06.015</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunnarsson, L. G. &amp; Bodin, L. Amyotrophic lateral sclerosis and occupational exposures: a systematic literature review and meta-analyses. Int. J. Environ. Res. Public Health 15, 2371 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30373166</ArticleId><ArticleId IdType="pmc">6265680</ArticleId><ArticleId IdType="doi">10.3390/ijerph15112371</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, F. C. et al. Association of environmental toxins with amyotrophic lateral sclerosis. JAMA Neurol. 73, 803&#x2013;811 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27159543</ArticleId><ArticleId IdType="pmc">5032145</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2016.0594</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti, M. et al. Pesticides, polychlorinated biphenyls and polycyclic aromatic hydrocarbons in cerebrospinal fluid of amyotrophic lateral sclerosis patients: a case&#x2013;control study. Environ. Res. 155, 261&#x2013;267 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28242563</ArticleId><ArticleId IdType="doi">10.1016/j.envres.2017.02.025</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti, M. et al. Pesticide exposure assessed through agricultural crop proximity and risk of amyotrophic lateral sclerosis. Environ. Health 16, 91 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28851431</ArticleId><ArticleId IdType="pmc">5576246</ArticleId><ArticleId IdType="doi">10.1186/s12940-017-0297-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew, A. et al. Pesticides applied to crops and amyotrophic lateral sclerosis risk in the U.S. Neurotoxicology 87, 128&#x2013;135 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34562505</ArticleId><ArticleId IdType="doi">10.1016/j.neuro.2021.09.004</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew, A. et al. Airborne lead and polychlorinated biphenyls (PCBs) are associated with amyotrophic lateral sclerosis (ALS) risk in the U.S. Sci. Total Environ. 819, 153096 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35041949</ArticleId><ArticleId IdType="doi">10.1016/j.scitotenv.2022.153096</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman, S. A. et al. Associations of self-reported occupational exposures and settings to ALS: a case&#x2013;control study. Int. Arch. Occup. Environ. Health 95, 1567&#x2013;1586 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35593931</ArticleId><ArticleId IdType="pmc">9424174</ArticleId><ArticleId IdType="doi">10.1007/s00420-022-01874-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman, S. A. et al. Occupational history associates with ALS survival and onset segment. Amyotroph. Lateral Scler. Frontotemporal Degener. 24, 219&#x2013;229 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36193557</ArticleId><ArticleId IdType="doi">10.1080/21678421.2022.2127324</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini, T. et al. Environmental and occupational risk factors of amyotrophic lateral sclerosis: a population-based case&#x2013;control study. Int. J. Environ. Res. Public Health 17, 2882 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32331298</ArticleId><ArticleId IdType="pmc">7216189</ArticleId><ArticleId IdType="doi">10.3390/ijerph17082882</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew, A. S. et al. Risk factors for amyotrophic lateral sclerosis: a regional United States case&#x2013;control study. Muscle Nerve 63, 52&#x2013;59 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33006184</ArticleId><ArticleId IdType="doi">10.1002/mus.27085</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew, A. S. et al. Environmental and occupational exposures and amyotrophic lateral sclerosis in New England. Neurodegener. Dis. 17, 110&#x2013;116 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28122372</ArticleId><ArticleId IdType="doi">10.1159/000453359</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, T. L. et al. Occupational exposures and the risk of amyotrophic lateral sclerosis. Occup. Environ. Med. 74, 87&#x2013;92 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27418175</ArticleId><ArticleId IdType="doi">10.1136/oemed-2016-103700</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson, A. S., Hansen, J., Gredal, O. &amp; Weisskopf, M. G. Study of occupational chromium, iron, and nickel exposure and amyotrophic lateral sclerosis in Denmark. Int. J. Environ. Res. Public Health 17, 8086 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33147887</ArticleId><ArticleId IdType="pmc">7663552</ArticleId><ArticleId IdType="doi">10.3390/ijerph17218086</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson, A. S., Hansen, J., Specht, A. J., Gredal, O. &amp; Weisskopf, M. G. Population-based study of amyotrophic lateral sclerosis and occupational lead exposure in Denmark. Occup. Environ. Med. 76, 208&#x2013;214 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30705111</ArticleId><ArticleId IdType="doi">10.1136/oemed-2018-105469</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto, H. et al. Case&#x2013;control study in ALS using the National ALS Registry: lead and agricultural chemicals are potential risk factors. Amyotroph. Lateral Scler. Frontotemporal Degener. 23, 190&#x2013;202 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34137650</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1936556</ArticleId></ArticleIdList></Reference><Reference><Citation>Visser, A. E. et al. Multicentre, population-based, case&#x2013;control study of particulates, combustion products and amyotrophic lateral sclerosis risk. J. Neurol. Neurosurg. Psychiatry 90, 854&#x2013;860 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30850472</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2018-319779</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickerson, A. S., Hansen, J., Gredal, O. &amp; Weisskopf, M. G. Amyotrophic lateral sclerosis and exposure to diesel exhaust in a Danish cohort. Am. J. Epidemiol. 187, 1613&#x2013;1622 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29590300</ArticleId><ArticleId IdType="pmc">6070035</ArticleId><ArticleId IdType="doi">10.1093/aje/kwy069</ArticleId></ArticleIdList></Reference><Reference><Citation>Seals, R. M., Kioumourtzoglou, M. A., Gredal, O., Hansen, J. &amp; Weisskopf, M. G. Occupational formaldehyde and amyotrophic lateral sclerosis. Eur. J. Epidemiol. 32, 893&#x2013;899 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28585120</ArticleId><ArticleId IdType="pmc">5681368</ArticleId><ArticleId IdType="doi">10.1007/s10654-017-0249-8</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay, K. A. et al. Military service and related risk factors for amyotrophic lateral sclerosis. Acta Neurol. Scand. 143, 39&#x2013;50 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32905613</ArticleId><ArticleId IdType="doi">10.1111/ane.13345</ArticleId></ArticleIdList></Reference><Reference><Citation>Cragg, J. J., Johnson, N. J. &amp; Weisskopf, M. G. Military service and amyotrophic lateral sclerosis in a population-based cohort: extended follow-up 1979-2011. Epidemiology 28, e15&#x2013;e16 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27893489</ArticleId><ArticleId IdType="pmc">5285394</ArticleId><ArticleId IdType="doi">10.1097/EDE.0000000000000589</ArticleId></ArticleIdList></Reference><Reference><Citation>Sagiraju, H. K. R. et al. Amyotrophic lateral sclerosis among veterans deployed in support of post-9/11 U.S. conflicts. Mil. Med. 185, e501&#x2013;e509 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31642489</ArticleId><ArticleId IdType="doi">10.1093/milmed/usz350</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, L. et al. Global variation in prevalence and incidence of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J. Neurol. 267, 944&#x2013;953 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31797084</ArticleId><ArticleId IdType="doi">10.1007/s00415-019-09652-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo, G. et al. A systematic review on the risk of neurodegenerative diseases and neurocognitive disorders in professional and varsity athletes. Neurol. Sci. 43, 6667&#x2013;6691 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35976476</ArticleId><ArticleId IdType="pmc">9663371</ArticleId><ArticleId IdType="doi">10.1007/s10072-022-06319-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Daneshvar, D. H. et al. Incidence of and mortality from amyotrophic lateral sclerosis in National Football League athletes. JAMA Netw. Open 4, e2138801 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34910152</ArticleId><ArticleId IdType="pmc">8674746</ArticleId><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.38801</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo, E. et al. Increased risk and early onset of ALS in professional players from Italian Soccer Teams. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 403&#x2013;409 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32321311</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1752250</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell, E. R. et al. Association of field position and career length with risk of neurodegenerative disease in male former professional soccer players. JAMA Neurol. 78, 1057&#x2013;1063 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34338724</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2021.2403</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang, F. et al. Amyotrophic lateral sclerosis among cross-country skiers in Sweden. Eur. J. Epidemiol. 31, 247&#x2013;253 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26220522</ArticleId><ArticleId IdType="doi">10.1007/s10654-015-0077-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman, L., Cooper-Knock, J. &amp; Shaw, P. J. Physical activity as an exogenous risk factor for amyotrophic lateral sclerosis: a review of the evidence. Brain 146, 1745&#x2013;1757 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36918362</ArticleId><ArticleId IdType="pmc">10151186</ArticleId><ArticleId IdType="doi">10.1093/brain/awac470</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero, C. et al. Early life metal dysregulation in amyotrophic lateral sclerosis. Ann. Clin. Transl. Neurol. 7, 872&#x2013;882 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32438517</ArticleId><ArticleId IdType="pmc">7318091</ArticleId><ArticleId IdType="doi">10.1002/acn3.51006</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrew, A. S. et al. Toenail mercury levels are associated with amyotrophic lateral sclerosis risk. Muscle Nerve https://doi.org/10.1002/mus.26055 (2018).</Citation></Reference><Reference><Citation>Andrew, A. S. et al. Keratinous biomarker of mercury exposure associated with amyotrophic lateral sclerosis risk in a nationwide U.S. study. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 420&#x2013;427 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32329357</ArticleId><ArticleId IdType="pmc">7483924</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1753777</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, S. et al. Blood metal levels and amyotrophic lateral sclerosis risk: a prospective cohort. Ann. Neurol. 89, 125&#x2013;133 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33068316</ArticleId><ArticleId IdType="doi">10.1002/ana.25932</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti, M. et al. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: a case&#x2013;control study. J. Trace Elem. Med. Biol. 43, 121&#x2013;125 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28089071</ArticleId><ArticleId IdType="pmc">5495626</ArticleId><ArticleId IdType="doi">10.1016/j.jtemb.2016.12.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidotti, T. L., Audette, R. J. &amp; Martin, C. J. Interpretation of the trace metal analysis profile for patients occupationally exposed to metals. Occup. Med. 47, 497&#x2013;503 (1997).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/47.8.497</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney, J. et al. No association between soil constituents and amyotrophic lateral sclerosis relative risk in Ireland. Environ. Res. 147, 102&#x2013;107 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26855128</ArticleId><ArticleId IdType="doi">10.1016/j.envres.2016.01.038</ArticleId></ArticleIdList></Reference><Reference><Citation>Parks, R. M. et al. Long-term traffic-related air pollutant exposure and amyotrophic lateral sclerosis diagnosis in Denmark: a Bayesian hierarchical analysis. Epidemiology 33, 757&#x2013;766 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35944145</ArticleId><ArticleId IdType="doi">10.1097/EDE.0000000000001536</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, Z. et al. Long-term exposure to ultrafine particles and particulate matter constituents and the risk of amyotrophic lateral sclerosis. Environ. Health Perspect. 129, 97702 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34498494</ArticleId><ArticleId IdType="doi">10.1289/EHP9131</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelen, M. et al. Long-term air pollution exposure and amyotrophic lateral sclerosis in Netherlands: a population-based case&#x2013;control study. Environ. Health Perspect. 125, 097023 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29989551</ArticleId><ArticleId IdType="pmc">5915195</ArticleId><ArticleId IdType="doi">10.1289/EHP1115</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek, A. M. et al. Long-term air pollution and risk of amyotrophic lateral sclerosis mortality in the Women&#x2019;s Health Initiative cohort. Environ. Res. 216, 114510 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36220441</ArticleId><ArticleId IdType="doi">10.1016/j.envres.2022.114510</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini, T. et al. Risk of amyotrophic lateral sclerosis and exposure to particulate matter from vehicular traffic: a case&#x2013;control study. Int. J. Environ. Res. Public Health 18, 973 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33499343</ArticleId><ArticleId IdType="pmc">7908475</ArticleId><ArticleId IdType="doi">10.3390/ijerph18030973</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunez, Y. et al. PM(2.5) composition and disease aggravation in amyotrophic lateral sclerosis: an analysis of long-term exposure to components of fine particulate matter in New York State. Environ. Epidemiol. 6, e204 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35434459</ArticleId><ArticleId IdType="pmc">9005248</ArticleId><ArticleId IdType="doi">10.1097/EE9.0000000000000204</ArticleId></ArticleIdList></Reference><Reference><Citation>Myung, W., Lee, H. &amp; Kim, H. Short-term air pollution exposure and emergency department visits for amyotrophic lateral sclerosis: a time-stratified case-crossover analysis. Environ. Int. 123, 467&#x2013;475 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30622072</ArticleId><ArticleId IdType="doi">10.1016/j.envint.2018.12.042</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomsen, G. M. et al. A model of recurrent concussion that leads to long-term motor deficits, CTE-like tauopathy and exacerbation of an ALS phenotype. J. Trauma Acute Care Surg. 81, 1070&#x2013;1079 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27602892</ArticleId><ArticleId IdType="doi">10.1097/TA.0000000000001248</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson, E. N. et al. Traumatic injury induces stress granule formation and enhances motor dysfunctions in ALS/FTD models. Hum. Mol. Genet. 27, 1366&#x2013;1381 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29432563</ArticleId><ArticleId IdType="pmc">6455923</ArticleId><ArticleId IdType="doi">10.1093/hmg/ddy047</ArticleId></ArticleIdList></Reference><Reference><Citation>Walt, G. S. et al. Chronic traumatic encephalopathy within an amyotrophic lateral sclerosis brain bank cohort. J. Neuropathol. Exp. Neurol. 77, 1091&#x2013;1100 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30299493</ArticleId><ArticleId IdType="pmc">6927868</ArticleId><ArticleId IdType="doi">10.1093/jnen/nly092</ArticleId></ArticleIdList></Reference><Reference><Citation>Blecher, R. et al. Contact sports as a risk factor for amyotrophic lateral sclerosis: a systematic review. Glob. Spine J. 9, 104&#x2013;118 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2192568218813916</ArticleId></ArticleIdList></Reference><Reference><Citation>Iverson, G. L. et al. Examining later-in-life health risks associated with sport-related concussion and repetitive head impacts: a systematic review of case&#x2013;control and cohort studies. Br. J. Sports Med. 57, 810&#x2013;821 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37316187</ArticleId><ArticleId IdType="doi">10.1136/bjsports-2023-106890</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini, T. et al. Clinical and lifestyle factors and risk of amyotrophic lateral sclerosis: a population-based case&#x2013;control study. Int. J. Environ. Res. Public Health 17, 857 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32019087</ArticleId><ArticleId IdType="pmc">7037077</ArticleId><ArticleId IdType="doi">10.3390/ijerph17030857</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo, E. et al. Trauma and amyotrophic lateral sclerosis: a European population-based case&#x2013;control study from the EURALS consortium. Amyotroph. Lateral Scler. Frontotemporal Degener. 19, 118&#x2013;125 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29063790</ArticleId><ArticleId IdType="doi">10.1080/21678421.2017.1386687</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu, D. et al. Trauma and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph. Lateral Scler. Frontotemporal Degener. 22, 170&#x2013;185 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33423565</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1861024</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitt, B. B., Lai, H. C. &amp; Manville, A. M. Effects of non-ionizing electromagnetic fields on flora and fauna, part 1. Rising ambient EMF levels in the environment. Rev. Environ. Health 37, 81&#x2013;122 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34047144</ArticleId><ArticleId IdType="doi">10.1515/reveh-2021-0026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, C., Zuo, H. &amp; Li, Y. Effects of radiofrequency electromagnetic radiation on neurotransmitters in the brain. Front. Public Health 9, 691880 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34485223</ArticleId><ArticleId IdType="pmc">8415840</ArticleId><ArticleId IdType="doi">10.3389/fpubh.2021.691880</ArticleId></ArticleIdList></Reference><Reference><Citation>Luna, J. et al. Residential exposure to ultra high frequency electromagnetic fields emitted by Global system for mobile (GSM) antennas and amyotrophic lateral sclerosis incidence: a geo-epidemiological population-based study. Environ. Res. 176, 108525 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31226626</ArticleId><ArticleId IdType="doi">10.1016/j.envres.2019.108525</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, S. et al. Associations of electric shock and extremely low-frequency magnetic field exposure with the risk of amyotrophic lateral sclerosis. Am. J. Epidemiol. 188, 796&#x2013;805 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30649156</ArticleId><ArticleId IdType="doi">10.1093/aje/kwy287</ArticleId></ArticleIdList></Reference><Reference><Citation>Koeman, T. et al. Occupational exposure and amyotrophic lateral sclerosis in a prospective cohort. Occup. Environ. Med. 74, 578&#x2013;585 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28356332</ArticleId><ArticleId IdType="doi">10.1136/oemed-2016-103780</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti, M. et al. Magnetic fields exposure from high-voltage power lines and risk of amyotrophic lateral sclerosis in two Italian populations. Amyotroph. Lateral Scler. Frontotemporal Degener. 18, 583&#x2013;589 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28569083</ArticleId><ArticleId IdType="doi">10.1080/21678421.2017.1332078</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippini, T., Hatch, E. E. &amp; Vinceti, M. Residential exposure to electromagnetic fields and risk of amyotrophic lateral sclerosis: a dose&#x2013;response meta-analysis. Sci. Rep. 11, 11939 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34099747</ArticleId><ArticleId IdType="pmc">8185090</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-91349-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Boddy, S. L. et al. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS). BMC Med. 19, 13 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33468103</ArticleId><ArticleId IdType="pmc">7816375</ArticleId><ArticleId IdType="doi">10.1186/s12916-020-01885-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson, K. et al. The human gut microbiota in people with amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 22, 186&#x2013;194 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33135936</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1828475</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gioia, D. et al. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis. BMC Med. 18, 153 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32546239</ArticleId><ArticleId IdType="pmc">7298784</ArticleId><ArticleId IdType="doi">10.1186/s12916-020-01607-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertzberg, V. S. et al. Gut microbiome differences between amyotrophic lateral sclerosis patients and spouse controls. Amyotroph. Lateral Scler. Frontotemporal Degener. 23, 91&#x2013;99 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">33818222</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1904994</ArticleId></ArticleIdList></Reference><Reference><Citation>Niccolai, E. et al. The gut microbiota&#x2013;immunity axis in ALS: a role in deciphering disease heterogeneity? Biomedicines 9, 753 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34209688</ArticleId><ArticleId IdType="pmc">8301418</ArticleId><ArticleId IdType="doi">10.3390/biomedicines9070753</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, H. S. et al. Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset. BMC Neurol. 22, 62 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35189854</ArticleId><ArticleId IdType="pmc">8862222</ArticleId><ArticleId IdType="doi">10.1186/s12883-022-02586-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu, H., Kim, S. H., Noh, M. Y., Lee, S. &amp; Park, Y. Relationship between dietary fiber intake and the prognosis of amyotrophic lateral sclerosis in Korea. Nutrients 12, 3420 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33171846</ArticleId><ArticleId IdType="pmc">7695159</ArticleId><ArticleId IdType="doi">10.3390/nu12113420</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo, S. T. et al. Progression and survival of patients with motor neuron disease relative to their fecal microbiota. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 549&#x2013;562 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32643435</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1772825</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman, S. A. et al. Metabolomics identifies shared lipid pathways in independent amyotrophic lateral sclerosis cohorts. Brain 145, 4425&#x2013;4439 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35088843</ArticleId><ArticleId IdType="pmc">9762943</ArticleId><ArticleId IdType="doi">10.1093/brain/awac025</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, Q. et al. The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients. Sci. Rep. 10, 12998 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32747678</ArticleId><ArticleId IdType="pmc">7398913</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-69845-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong, Z. et al. Gut microbiota links with cognitive impairment in amyotrophic lateral sclerosis: a multi-omics study. J. Biomed. Res. 37, 125&#x2013;137 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36814376</ArticleId><ArticleId IdType="pmc">10018415</ArticleId><ArticleId IdType="doi">10.7555/JBR.36.20220198</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, L., Zhuang, Z., Zhang, G., Huang, T. &amp; Fan, D. Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: a 2-sample Mendelian randomization study. BMC Neurol. 22, 8 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34979977</ArticleId><ArticleId IdType="pmc">8721912</ArticleId><ArticleId IdType="doi">10.1186/s12883-021-02522-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning, J. et al. Investigating casual associations among gut microbiota, metabolites, and neurodegenerative diseases: a Mendelian randomization study. J. Alzheimers Dis. 87, 211&#x2013;222 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35275534</ArticleId><ArticleId IdType="doi">10.3233/JAD-215411</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanedo-Vazquez, D., Bosque-Varela, P., Sainz-Pelayo, A. &amp; Riancho, J. Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration. J. Neurol. 266, 27&#x2013;36 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">29845377</ArticleId><ArticleId IdType="doi">10.1007/s00415-018-8919-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine, K. S. et al. Virus exposure and neurodegenerative disease risk across national biobanks. Neuron 111, 1086&#x2013;1093.e2 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36669485</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2022.12.029</ArticleId></ArticleIdList></Reference><Reference><Citation>French, P. W., Ludowyke, R. &amp; Guillemin, G. J. Fungal neurotoxins and sporadic amyotrophic lateral sclerosis. Neurotox. Res. 35, 969&#x2013;980 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30515715</ArticleId><ArticleId IdType="doi">10.1007/s12640-018-9980-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce, E. S. How did Lou Gehrig get Lou Gehrig&#x2019;s disease? Mycobacterium avium subspecies paratuberculosis in manure, soil, dirt, dust and grass and amyotrophic lateral sclerosis (motor neurone disease) clusters in football, rugby and soccer players. Med. Hypotheses 119, 1&#x2013;5 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30122477</ArticleId><ArticleId IdType="doi">10.1016/j.mehy.2018.07.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Pape, J. A. &amp; Grose, J. H. The effects of diet and sex in amyotrophic lateral sclerosis. Rev. Neurol. 176, 301&#x2013;315 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32147204</ArticleId><ArticleId IdType="doi">10.1016/j.neurol.2019.09.008</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico, E. et al. Metabolic abnormalities, dietary risk factors and nutritional management in amyotrophic lateral sclerosis. Nutrients 13, 2273 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34209133</ArticleId><ArticleId IdType="pmc">8308334</ArticleId><ArticleId IdType="doi">10.3390/nu13072273</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman, M. H. et al. Effect of presymptomatic body mass index and consumption of fat and alcohol on amyotrophic lateral sclerosis. JAMA Neurol. 72, 1155&#x2013;1162 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26280944</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2015.1584</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng, H. J. et al. Associations between lifestyle and amyotrophic lateral sclerosis stratified by C9orf72 genotype: a longitudinal, population-based, case-control study. Lancet Neurol. 20, 373&#x2013;384 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33894192</ArticleId><ArticleId IdType="doi">10.1016/S1474-4422(21)00042-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman, S. A. et al. Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles. Muscle Nerve 67, 208&#x2013;216 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36321729</ArticleId><ArticleId IdType="doi">10.1002/mus.27744</ArticleId></ArticleIdList></Reference><Reference><Citation>Fitzgerald, K. C. et al. Dietary &#x3c9;-3 polyunsaturated fatty acid intake and risk for amyotrophic lateral sclerosis. JAMA Neurol. 71, 1102&#x2013;1110 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25023276</ArticleId><ArticleId IdType="pmc">4160351</ArticleId><ArticleId IdType="doi">10.1001/jamaneurol.2014.1214</ArticleId></ArticleIdList></Reference><Reference><Citation>Michels, S. et al. Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry. J. Neurol. 270, 3082&#x2013;3090 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36853389</ArticleId><ArticleId IdType="pmc">10193299</ArticleId><ArticleId IdType="doi">10.1007/s00415-023-11630-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Hop, P. J. et al. Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS. Sci. Transl. Med. 14, eabj0264 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35196023</ArticleId><ArticleId IdType="pmc">10040186</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abj0264</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo, E. et al. Amyotrophic lateral sclerosis and food intake. Amyotroph. Lateral Scler. Frontotemporal Degener. 19, 267&#x2013;274 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29268633</ArticleId><ArticleId IdType="doi">10.1080/21678421.2017.1418002</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin, Y. et al. Dietary intake of fruits and beta-carotene is negatively associated with amyotrophic lateral sclerosis risk in Koreans: a case&#x2013;control study. Nutr. Neurosci. 17, 104&#x2013;108 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">23710627</ArticleId><ArticleId IdType="doi">10.1179/1476830513Y.0000000071</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamoto, K. et al. Fruit and vegetable intake and risk of amyotrophic lateral sclerosis in Japan. Neuroepidemiology 32, 251&#x2013;256 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19209004</ArticleId><ArticleId IdType="doi">10.1159/000201563</ArticleId></ArticleIdList></Reference><Reference><Citation>Petimar, J. et al. Coffee, tea, and caffeine intake and amyotrophic lateral sclerosis mortality in a pooled analysis of eight prospective cohort studies. Eur. J. Neurol. 26, 468&#x2013;475 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30326172</ArticleId><ArticleId IdType="doi">10.1111/ene.13840</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncharova, P. S. et al. Nutrient effects on motor neurons and the risk of amyotrophic lateral sclerosis. Nutrients 13, 3804 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34836059</ArticleId><ArticleId IdType="pmc">8622539</ArticleId><ArticleId IdType="doi">10.3390/nu13113804</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia, K. et al. Dietary-derived essential nutrients and amyotrophic lateral sclerosis: a two-sample Mendelian randomization study. Nutrients 14, 920 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35267896</ArticleId><ArticleId IdType="pmc">8912818</ArticleId><ArticleId IdType="doi">10.3390/nu14050920</ArticleId></ArticleIdList></Reference><Reference><Citation>Joo, J., Williamson, S. A., Vazquez, A. I., Fernandez, J. R. &amp; Bray, M. S. The influence of 15-week exercise training on dietary patterns among young adults. Int. J. Obes. 43, 1681&#x2013;1690 (2019).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41366-018-0299-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian, T. H. et al. A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain 145, 832&#x2013;842 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34791088</ArticleId><ArticleId IdType="doi">10.1093/brain/awab420</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry, K. A., Fagliano, J., Jordan, H. M., Rechtman, L. &amp; Kaye, W. E. Geographic variation of amyotrophic lateral sclerosis incidence in New Jersey, 2009&#x2013;2011. Am. J. Epidemiol. 182, 512&#x2013;519 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26041711</ArticleId><ArticleId IdType="pmc">4564938</ArticleId><ArticleId IdType="doi">10.1093/aje/kwv095</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian, L. et al. Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case&#x2013;control study of ALS in China. J. Clin. Neurosci. 66, 12&#x2013;18 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31155341</ArticleId><ArticleId IdType="doi">10.1016/j.jocn.2019.05.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudin, M., Salachas, F., Pradat, P. F. &amp; Dupr&#xe9;, N. Environmental risk factors for amyotrophic lateral sclerosis: a case&#x2013;control study in Canada and France. Amyotroph. Lateral Scler. Frontotemporal Degener. 23, 592&#x2013;600 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35084274</ArticleId><ArticleId IdType="doi">10.1080/21678421.2022.2028167</ArticleId></ArticleIdList></Reference><Reference><Citation>Korner, S. et al. Influence of environment and lifestyle on incidence and progress of amyotrophic lateral sclerosis in a German ALS population. Aging Dis. 10, 205&#x2013;216 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31011473</ArticleId><ArticleId IdType="pmc">6457054</ArticleId><ArticleId IdType="doi">10.14336/AD.2018.0327</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters, S. et al. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. J. Neurol. Neurosurg. Psychiatry 91, 33&#x2013;39 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31434759</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2019-320986</ArticleId></ArticleIdList></Reference><Reference><Citation>Keren, N. et al. Evidence of an environmental effect on survival in ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 15, 528&#x2013;533 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24862874</ArticleId><ArticleId IdType="doi">10.3109/21678421.2014.911326</ArticleId></ArticleIdList></Reference><Reference><Citation>Rooney, J. et al. Survival analysis of geospatial factors in the Irish ALS cohort. Amyotroph. Lateral Scler. Frontotemporal Degener. 17, 555&#x2013;560 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27145090</ArticleId><ArticleId IdType="doi">10.1080/21678421.2016.1179326</ArticleId></ArticleIdList></Reference><Reference><Citation>Goutman, S. A. et al. High plasma concentrations of organic pollutants negatively impact survival in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 90, 907&#x2013;912 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30760645</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2018-319785</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrugia Wismayer, M. et al. Occupation and amyotrophic lateral sclerosis risk: a case&#x2013;control study in the isolated island population of Malta. Amyotroph. Lateral Scler. Frontotemporal Degener. 22, 528&#x2013;534 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33821701</ArticleId><ArticleId IdType="doi">10.1080/21678421.2021.1905847</ArticleId></ArticleIdList></Reference><Reference><Citation>Furby, A., Beauvais, K., Kolev, I., Rivain, J. G. &amp; S&#xe9;bille, V. Rural environment and risk factors of amyotrophic lateral sclerosis: a case&#x2013;control study. J. Neurol. 257, 792&#x2013;798 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20012543</ArticleId><ArticleId IdType="doi">10.1007/s00415-009-5419-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio, A. et al. ALS in Italian professional soccer players: the risk is still present and could be soccer-specific. Amyotroph. Lateral Scler. 10, 205&#x2013;209 (2009).</Citation><ArticleIdList><ArticleId IdType="pubmed">19267274</ArticleId><ArticleId IdType="doi">10.1080/17482960902721634</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2;, A., Benzi, G., Dossena, M., Mutani, R. &amp; Mora, G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain 128, 472&#x2013;476 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15634730</ArticleId><ArticleId IdType="doi">10.1093/brain/awh373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotkine, M., Friedlander, Y. &amp; Hochner, H. Triathletes are over-represented in a population of patients with ALS. Amyotroph. Lateral Scler. Frontotemporal Degener. 15, 534&#x2013;536 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25007701</ArticleId><ArticleId IdType="doi">10.3109/21678421.2014.932383</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamez, J. &amp; Carmona, F. Confirmation of early non-bulbar onset of amyotrophic lateral sclerosis in Spanish league soccer players. J. Neurol. Sci. 428, 117586 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34343861</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2021.117586</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar, M. et al. Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain 145, 27&#x2013;44 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34677606</ArticleId><ArticleId IdType="doi">10.1093/brain/awab404</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills, A. M. et al. Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet 383, 2065&#x2013;2072 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24582471</ArticleId><ArticleId IdType="pmc">4176708</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(14)60222-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph, A. C. et al. Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann. Neurol. 87, 206&#x2013;216 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31849093</ArticleId><ArticleId IdType="doi">10.1002/ana.25661</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst, J. et al. Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry 91, 1007&#x2013;1009 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32788256</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2020-323372</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi, F. et al. Study protocol on the safety and feasibility of a normocaloric ketogenic diet in people with amyotrophic lateral sclerosis. Nutrition 94, 111525 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34864433</ArticleId><ArticleId IdType="doi">10.1016/j.nut.2021.111525</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni, S. &amp; Wills, A. M. High-fat and ketogenic diets in amyotrophic lateral sclerosis. J. Child Neurol. 28, 989&#x2013;992 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23666040</ArticleId><ArticleId IdType="pmc">4438106</ArticleId><ArticleId IdType="doi">10.1177/0883073813488669</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi, F., Venkatesan, S., Saraceno, M., Mazzini, L. &amp; Grossini, E. Acetyl-L-carnitine and amyotrophic lateral sclerosis: current evidence and potential use. CNS Neurol. Disord. Drug. Targets https://doi.org/10.2174/1871527322666230330083757 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527322666230330083757</ArticleId><ArticleId IdType="pubmed">37291780</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong, C. et al. Clinical trials in amyotrophic lateral sclerosis: a systematic review and perspective. Brain Commun. 3, fcab242 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34901853</ArticleId><ArticleId IdType="pmc">8659356</ArticleId><ArticleId IdType="doi">10.1093/braincomms/fcab242</ArticleId></ArticleIdList></Reference><Reference><Citation>Blacher, E. et al. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature 572, 474&#x2013;480 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31330533</ArticleId><ArticleId IdType="doi">10.1038/s41586-019-1443-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Burberry, A. et al. C9orf72 suppresses systemic and neural inflammation induced by gut bacteria. Nature 582, 89&#x2013;94 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32483373</ArticleId><ArticleId IdType="pmc">7416879</ArticleId><ArticleId IdType="doi">10.1038/s41586-020-2288-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli, J. et al. FETR-ALS study protocol: a randomized clinical trial of fecal microbiota transplantation in amyotrophic lateral sclerosis. Front. Neurol. 10, 1021 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31620079</ArticleId><ArticleId IdType="pmc">6763586</ArticleId><ArticleId IdType="doi">10.3389/fneur.2019.01021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, G., Wen, Q., Cui, B., Li, Q. &amp; Zhang, F. Washed microbiota transplantation stopped the deterioration of amyotrophic lateral sclerosis: the first case report and narrative review. J. Biomed. Res. 37, 69&#x2013;76 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35821195</ArticleId><ArticleId IdType="pmc">9898040</ArticleId><ArticleId IdType="doi">10.7555/JBR.36.20220088</ArticleId></ArticleIdList></Reference><Reference><Citation>Paoli, A. et al. Ketogenic diet and microbiota: friends or enemies? Genes 10, 534 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31311141</ArticleId><ArticleId IdType="pmc">6678592</ArticleId><ArticleId IdType="doi">10.3390/genes10070534</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawat, K., Singh, N., Kumari, P. &amp; Saha, L. A review on preventive role of ketogenic diet (KD) in CNS disorders from the gut microbiota perspective. Rev. Neurosci. 32, 143&#x2013;157 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33070123</ArticleId><ArticleId IdType="doi">10.1515/revneuro-2020-0078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wosiski-Kuhn, M., Lyon, M. S., Caress, J. &amp; Milligan, C. Inflammation, immunity, and amyotrophic lateral sclerosis: II. immune-modulating therapies. Muscle Nerve 59, 23&#x2013;33 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">29979478</ArticleId><ArticleId IdType="doi">10.1002/mus.26288</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, F. O. et al. Exposure to an environmental neurotoxicant hastens the onset of amyotrophic lateral sclerosis-like phenotype in human Cu<sup>2+</sup>/Zn<sup>2+</sup> superoxide dismutase 1 G93A mice: glutamate-mediated excitotoxicity. J. Pharmacol. Exp. Ther. 338, 518&#x2013;527 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21586603</ArticleId><ArticleId IdType="pmc">3141904</ArticleId><ArticleId IdType="doi">10.1124/jpet.110.174466</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey, J. M., Col&#xf3;n-Rodr&#xed;guez, A. &amp; Atchison, W. D. Evaluating a gene&#x2013;environment interaction in amyotrophic lateral sclerosis: methylmercury exposure and mutated SOD1. Curr. Environ. Health Rep. 4, 200&#x2013;207 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28397096</ArticleId><ArticleId IdType="pmc">5494256</ArticleId><ArticleId IdType="doi">10.1007/s40572-017-0144-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash, P. E. A. et al. Heavy metal neurotoxicants induce ALS-linked TDP-43 pathology. Toxicol. Sci. 167, 105&#x2013;115 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30371865</ArticleId><ArticleId IdType="doi">10.1093/toxsci/kfy267</ArticleId></ArticleIdList></Reference><Reference><Citation>Koski, L., Ronnevi, C., Berntsson, E., W&#xe4;rml&#xe4;nder, S. &amp; Roos, P. M. Metals in ALS TDP-43 pathology. Int. J. Mol. Sci. 22, 12193 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34830074</ArticleId><ArticleId IdType="pmc">8622279</ArticleId><ArticleId IdType="doi">10.3390/ijms222212193</ArticleId></ArticleIdList></Reference><Reference><Citation>Minj, E., Upadhayay, S. &amp; Mehan, S. Nrf2/HO-1 signaling activator acetyl-11-keto-beta boswellic acid (AKBA)-mediated neuroprotection in methyl mercury-induced experimental model of ALS. Neurochem. Res. 46, 2867&#x2013;2884 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34075522</ArticleId><ArticleId IdType="doi">10.1007/s11064-021-03366-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Iqubal, A. et al. Environmental neurotoxic pollutants: review. Environ. Sci. Pollut. Res. Int. 27, 41175&#x2013;41198 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32820440</ArticleId><ArticleId IdType="doi">10.1007/s11356-020-10539-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Kisby, G. E. &amp; Spencer, P. S. Genotoxic damage during brain development presages prototypical neurodegenerative disease. Front. Neurosci. 15, 752153 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34924930</ArticleId><ArticleId IdType="pmc">8675606</ArticleId><ArticleId IdType="doi">10.3389/fnins.2021.752153</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagrange, E. et al. An amyotrophic lateral sclerosis hot spot in the French Alps associated with genotoxic fungi. J. Neurol. Sci. 427, 117558 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34216974</ArticleId><ArticleId IdType="doi">10.1016/j.jns.2021.117558</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa, L. G. et al. Neurotoxicity of traffic-related air pollution. Neurotoxicology 59, 133&#x2013;139 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">26610921</ArticleId><ArticleId IdType="doi">10.1016/j.neuro.2015.11.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan, Y. &amp; Nicolazzo, J. A. Altered blood&#x2013;brain barrier and blood&#x2013;spinal cord barrier dynamics in amyotrophic lateral sclerosis: impact on medication efficacy and safety. Br. J. Pharmacol. 179, 2577&#x2013;2588 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35048358</ArticleId><ArticleId IdType="doi">10.1111/bph.15802</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock, B. J., Goutman, S. A., Boss, J., Kim, S. &amp; Feldman, E. L. Amyotrophic lateral sclerosis survival associates with neutrophils in a sex-specific manner. Neurol. Neuroimmunol. Neuroinflamm. 8, e953 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33531377</ArticleId><ArticleId IdType="pmc">8057067</ArticleId><ArticleId IdType="doi">10.1212/NXI.0000000000000953</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafalou, S. &amp; Abdollahi, M. The link of organophosphorus pesticides with neurodegenerative and neurodevelopmental diseases based on evidence and mechanisms. Toxicology 409, 44&#x2013;52 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30053494</ArticleId><ArticleId IdType="doi">10.1016/j.tox.2018.07.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulick, D. et al. Amyotrophic lateral sclerosis-associated persistent organic pollutant cis-chlordane causes GABA(A)-independent toxicity to motor neurons, providing evidence toward an environmental component of sporadic amyotrophic lateral sclerosis. ACS Chem. Neurosci. 13, 3567&#x2013;3577 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36511510</ArticleId><ArticleId IdType="doi">10.1021/acschemneuro.2c00452</ArticleId></ArticleIdList></Reference><Reference><Citation>de Vos, W. M., Tilg, H., Van Hul, M. &amp; Cani, P. D. Gut microbiome and health: mechanistic insights. Gut 71, 1020&#x2013;1032 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35105664</ArticleId><ArticleId IdType="doi">10.1136/gutjnl-2021-326789</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, S., Yi, J., Zhang, Y. G., Zhou, J. &amp; Sun, J. Leaky intestine and impaired microbiome in an amyotrophic lateral sclerosis mouse model. Physiol. Rep. 3, e12356 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25847918</ArticleId><ArticleId IdType="pmc">4425962</ArticleId><ArticleId IdType="doi">10.14814/phy2.12356</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. G. et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin. Ther. 39, 322&#x2013;336 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28129947</ArticleId><ArticleId IdType="pmc">5344195</ArticleId><ArticleId IdType="doi">10.1016/j.clinthera.2016.12.014</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh, A., De Vadder, F., Kovatcheva-Datchary, P. &amp; B&#xe4;ckhed, F. From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165, 1332&#x2013;1345 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27259147</ArticleId><ArticleId IdType="doi">10.1016/j.cell.2016.05.041</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y., Ogbu, D., Garrett, S., Xia, Y. &amp; Sun, J. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis. Gut Microbes 13, 1996848 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34812107</ArticleId><ArticleId IdType="pmc">8632307</ArticleId><ArticleId IdType="doi">10.1080/19490976.2021.1996848</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg, M. S. et al. Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models. Sci. Rep. 10, 15583 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32973137</ArticleId><ArticleId IdType="pmc">7519132</ArticleId><ArticleId IdType="doi">10.1038/s41598-020-72638-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Trabjerg, M. S. et al. Downregulating carnitine palmitoyl transferase 1 affects disease progression in the SOD1 G93A mouse model of ALS. Commun. Biol. 4, 509 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33931719</ArticleId><ArticleId IdType="pmc">8087699</ArticleId><ArticleId IdType="doi">10.1038/s42003-021-02034-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Figueroa-Romero, C. et al. Temporal evolution of the microbiome, immune system and epigenome with disease progression in ALS mice. Dis. Model Mech. 13, dmm041947 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31597644</ArticleId><ArticleId IdType="pmc">6906635</ArticleId><ArticleId IdType="doi">10.1242/dmm.041947</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox, L. M. et al. The microbiota restrains neurodegenerative microglia in a model of amyotrophic lateral sclerosis. Microbiome 10, 47 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35272713</ArticleId><ArticleId IdType="pmc">8915543</ArticleId><ArticleId IdType="doi">10.1186/s40168-022-01232-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, L. et al. Associations of heavy metals with activities of daily living disability: an epigenome-wide view of DNA methylation and mediation analysis. Environ. Health Perspect. 130, 87009 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36036794</ArticleId><ArticleId IdType="doi">10.1289/EHP10602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoang, T. T. et al. Epigenome-wide DNA methylation and pesticide use in the agricultural lung health study. Environ. Health Perspect. 129, 97008 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34516295</ArticleId><ArticleId IdType="doi">10.1289/EHP8928</ArticleId></ArticleIdList></Reference><Reference><Citation>Grova, N., Schroeder, H., Olivier, J. L. &amp; Turner, J. D. Epigenetic and neurological impairments associated with early life exposure to persistent organic pollutants. Int. J. Genomics 2019, 2085496 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30733955</ArticleId><ArticleId IdType="pmc">6348822</ArticleId><ArticleId IdType="doi">10.1155/2019/2085496</ArticleId></ArticleIdList></Reference><Reference><Citation>Shock, T., Badang, L., Ferguson, B. &amp; Martinez-Guryn, K. The interplay between diet, gut microbes, and host epigenetics in health and disease. J. Nutr. Biochem. 95, 108631 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33789148</ArticleId><ArticleId IdType="pmc">8355029</ArticleId><ArticleId IdType="doi">10.1016/j.jnutbio.2021.108631</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante, X., Figueroa-Romero, C., Sakowski, S. A., Goutman, S. A. &amp; Feldman, E. L. Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era. Nat. Rev. Neurol. 11, 266&#x2013;279 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25896087</ArticleId><ArticleId IdType="doi">10.1038/nrneurol.2015.57</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Colasante, X. et al. Cytoplasmic TDP43 binds microRNAs: new disease targets in amyotrophic lateral sclerosis. Front. Cell. Neurosci. 14, 117 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32477070</ArticleId><ArticleId IdType="pmc">7235295</ArticleId><ArticleId IdType="doi">10.3389/fncel.2020.00117</ArticleId></ArticleIdList></Reference><Reference><Citation>Young, P. E., Kum Jew, S., Buckland, M. E., Pamphlett, R. &amp; Suter, C. M. Epigenetic differences between monozygotic twins discordant for amyotrophic lateral sclerosis (ALS) provide clues to disease pathogenesis. PLoS ONE 12, e0182638 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28797086</ArticleId><ArticleId IdType="pmc">5552194</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0182638</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruf, W. P. et al. Methylome analysis of ALS patients and presymptomatic mutation carriers in blood cells. Neurobiol. Aging 116, 16&#x2013;24 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35537341</ArticleId><ArticleId IdType="doi">10.1016/j.neurobiolaging.2022.04.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, M. et al. Combined epigenetic/genetic study identified an ALS age of onset modifier. Acta Neuropathol. Commun. 9, 75 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33892821</ArticleId><ArticleId IdType="pmc">8066440</ArticleId><ArticleId IdType="doi">10.1186/s40478-021-01183-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar, M., Wuu, J., Andersen, P. M., Lombardi, V. &amp; Malaspina, A. Neurofilament light: a candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion. Ann. Neurol. 84, 130&#x2013;139 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30014505</ArticleId><ArticleId IdType="doi">10.1002/ana.25276</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik, K. et al. Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis. Neurology 92, e2089&#x2013;e2100 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30926684</ArticleId><ArticleId IdType="pmc">6512888</ArticleId></ArticleIdList></Reference><Reference><Citation>Bjornevik, K. et al. Pre-diagnostic plasma lipid levels and the risk of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 22, 133&#x2013;143 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">32985910</ArticleId><ArticleId IdType="doi">10.1080/21678421.2020.1822411</ArticleId></ArticleIdList></Reference><Reference><Citation>Price, E. J. et al. Merging the exposome into an integrated framework for &#x2018;omics&#x2019; sciences. iScience 25, 103976 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35310334</ArticleId><ArticleId IdType="pmc">8924626</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2022.103976</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan, B. A. et al. Evaluation of the NAD(+) biosynthetic pathway in ALS patients and effect of modulating NAD(+) levels in hSOD1-linked ALS mouse models. Exp. Neurol. 327, 113219 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32014438</ArticleId><ArticleId IdType="pmc">7089832</ArticleId><ArticleId IdType="doi">10.1016/j.expneurol.2020.113219</ArticleId></ArticleIdList></Reference><Reference><Citation>Liguori, F., Amadio, S. &amp; Volont&#xe9;, C. Where and why modeling amyotrophic lateral sclerosis. Int. J. Mol. Sci. 22, 3977 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33921446</ArticleId><ArticleId IdType="pmc">8070525</ArticleId><ArticleId IdType="doi">10.3390/ijms22083977</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli, E. et al. Human stem cell models of neurodegeneration: from basic science of amyotrophic lateral sclerosis to clinical translation. Cell Stem Cell 29, 11&#x2013;35 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">34995492</ArticleId><ArticleId IdType="pmc">8785905</ArticleId><ArticleId IdType="doi">10.1016/j.stem.2021.12.008</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>